Kraemer R
Ther Umsch. 1989 Sep;46(9):602-9.
Anamnestic findings and clinical signs of wheezing attacks, which respond to beta-2-agonists, are the most important criteria in deciding whether a wheezy bronchitis is already a part of bronchial asthma. In this scope advanced lung function testing permits to search for functional abnormalities already in early childhood. Clinically, a study, carried out in ten ambulatory practices on about 1000 schoolchildren has shown that three diagnostic elements have to be distinguished. An "obstructive element" is based on the presence of clinical signs like cough, wheezing and rales. The "chronic element" is defined by the duration of the wheezing attacks and the number of attacks. Finally a third element, the "pulmonary hyperinflation" must clinically be recognized. The critical goals in the long term management of children with asthma are freedom of symptoms and optimal lung function. In this approach stratification into different aetiopathogenetic groups based on anamnestic, clinical and immuno-allergic findings is helpful and the follow-up of subclinical functional sequelae must be considered by repeated lung function tests. Only by these measures can the ongoing immuno-allergic process of airway inflammation be handled.
对β2受体激动剂有反应的喘息发作的既往史及临床体征,是判定喘息性支气管炎是否已属于支气管哮喘的最重要标准。在此范围内,先进的肺功能检测能够在儿童早期就查出功能异常。临床上,在10家门诊机构对约1000名学童开展的一项研究表明,有三个诊断要素需要区分。“阻塞性要素”基于咳嗽、喘息和啰音等临床体征的存在。“慢性要素”由喘息发作的持续时间和发作次数来定义。最后,第三个要素“肺过度充气”必须在临床上予以识别。哮喘患儿长期管理的关键目标是症状缓解和最佳肺功能。在这种方法中,根据既往史、临床及免疫过敏检查结果将患儿分层到不同的病因发病学组是有帮助的,并且必须通过重复肺功能检测来考虑亚临床功能后遗症的随访情况。只有通过这些措施,才能应对气道炎症持续存在的免疫过敏过程。